Clinical Trials in New York

Showing 17181-17200 of 22,668 trials

Pharmacology of Cognition in Schizotypal Personality Disorder

NCT00353379

This study will determine the effectiveness of guanfacine in improving cognitive and functional impairments in schizotypal personality disorder.

Schizotypal Personality DisorderPersonality Disorders

Icahn School of Medicine at Mount Sinai29 participantsStarted Sep 1995

New York, New York, United States

TERMINATEDPhase 4< 1 mile

Armodafinil for Patients Starting Hepatitis C Virus Treatment

NCT01470651

Fatigue is one of the most common side effects of the treatment of hepatitis C infection with pegylated interferon and ribavirin, and is a major cause of treatment discontinuation. Armodafinil is an FDA approved stimulant medication for the treatment of narcolepsy and shift-work sleep disorder. This is a randomized placebo controlled study to determine whether patients assigned to armodafinil have fewer missed doses, dose reductions or treatment discontinuation due to side effects in the first 12 weeks of treatment for hepatitis C infection than do placebo patients. Placebo patients are offered 14 weeks of open label armodafinil after Week 12.

Hepatitis C

Research Foundation for Mental Hygiene, Inc.26 participantsStarted Oct 2011

New York, New York, United States • New York, New York, United States

COMPLETED< 1 mile

ProMRI Study of the Entovis Pacemaker System

NCT01761162

The objective of the ProMRI Study is to demonstrate the clinical safety of the ProMRI Pacemaker System when used under specific MRI conditions.

Safety of the ProMRI Pacemaker System Under Specific MRI Conditions

Biotronik, Inc.229 participantsStarted Feb 2013

Scottsdale, Arizona, United States • Concord, California, United States • Newport Beach, California, United States +22 more locations

Pharmacology of Cognition in Schizotypal Personality Disorder

Armodafinil for Patients Starting Hepatitis C Virus Treatment

ProMRI Study of the Entovis Pacemaker System

Find Trials by Condition in New York

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers

First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

Pharmacokinetics of Voriconazole in Obese Subjects

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

EPO906 Therapy in Patients With Prostate Cancer

EPO906 Therapy in Patients With Advanced Breast Cancer

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes